Quidel Sofia 2 Flu+SARS Antigen FIA (25T)

Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.

Supplier:  Quidel 20377

Catalog No. 23-044-155

Description

• One Sample - Three Results
• Results in 15 minutes
• Dual Work Modes
• Virena Connection
• All necessary components included in kit
• Self-contained Test cassette
• For use with Sofia 2
• FDA Emergency Use Authorization.

Specifications

• Certifications/Compliance: End-User Placement Agreement Required
• Control Sets: Included and available for purchase
• Clia Complexity: Waived (EUA)
• Format: Immunofluorescence-based lateral flow technology
• Sensitivity: Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
• For Use With (Application): Instrument Read - advanced immunofluorescence-based lateral flow
• Quantity: 25
• Test Time: 15 min.

• Content And Storage: 15°C to 35°C
• CE Marker: No
• Detectable Analytes: Influenza A+B and COVID-19/2019-nCOV
• Sample Type: Direct: Nasal Swab, Nasopharyngael Swab
• Type: Rapid Test
• Packaging Type: 12 Kits/Cs.
• Specificity: Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%

Safety and Handling

ShelfLife : 12 Months from DOM